An intervention to decrease catheter-related bloodstream infections in the ICU
Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel, Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel
Abstract
Background: Catheter-related bloodstream infections occurring in the intensive care unit (ICU) are common, costly, and potentially lethal.
Methods: We conducted a collaborative cohort study predominantly in ICUs in Michigan. An evidence-based intervention was used to reduce the incidence of catheter-related bloodstream infections. Multilevel Poisson regression modeling was used to compare infection rates before, during, and up to 18 months after implementation of the study intervention. Rates of infection per 1000 catheter-days were measured at 3-month intervals, according to the guidelines of the National Nosocomial Infections Surveillance System.
Results: A total of 108 ICUs agreed to participate in the study, and 103 reported data. The analysis included 1981 ICU-months of data and 375,757 catheter-days. The median rate of catheter-related bloodstream infection per 1000 catheter-days decreased from 2.7 infections at baseline to 0 at 3 months after implementation of the study intervention (P< or =0.002), and the mean rate per 1000 catheter-days decreased from 7.7 at baseline to 1.4 at 16 to 18 months of follow-up (P<0.002). The regression model showed a significant decrease in infection rates from baseline, with incidence-rate ratios continuously decreasing from 0.62 (95% confidence interval [CI], 0.47 to 0.81) at 0 to 3 months after implementation of the intervention to 0.34 (95% CI, 0.23 to 0.50) at 16 to 18 months.
Conclusions: An evidence-based intervention resulted in a large and sustained reduction (up to 66%) in rates of catheter-related bloodstream infection that was maintained throughout the 18-month study period.
Copyright 2006 Massachusetts Medical Society.
Source: PubMed
다가오는 임상 시험
-
University of Colorado, DenverNational Institute on Aging (NIA); Aegis Therapies, Inc.모병
-
Centre Hospitalier de Cannes Simone VeilRéadapta 2C Centre de recherche en psychologie et neurosciences UMR 7077 AMU CNRS; Entité...아직 모집하지 않음불안 | Patient Resident Living in a Care Home프랑스
-
Beijing Inno Medicine Co., Ltd.모병
-
Memorial Sloan Kettering Cancer Center모병
-
Boehringer Ingelheim아직 모집하지 않음
-
Alejandro AlvaLuye Pharma Group Ltd.아직 모집하지 않음
-
The First Affiliated Hospital of Soochow University모병EBV Activation and EBV-PTLD After Allogeneic Hematopoietic Stem Cell Transplantation중국
-
AbbVie아직 모집하지 않음
-
IRCCS Eugenio MedeaIstituto Nazionale Assicurazione contro gli Infortuni sul Lavoro; Istituto di Sistemi e...모병뇌졸중 | 건강한 | 척수 손상이탈리아
-
University Hospitals Cleveland Medical Center아직 모집하지 않음
-
University of Lausanne아직 모집하지 않음
-
Xiangya Hospital of Central South University아직 모집하지 않음